SCOTT A RUNDLE MD
Prescription History 1891749347
Emergency Medicine in Whitefish, MT

NPI Status: Active since May 20, 2006

Contact Information

1600 HOSPITAL WAY
WHITEFISH, MT
ZIP 59937
Phone: (406) 863-3500
Fax: (406) 862-2510

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for SCOTT A RUNDLE MD, an active Emergency Medicine specialist practicing in Whitefish, MT. Our medical registry currently tracks 4 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 51 documented patient claims. Among these therapy options, the most frequently utilized medication is Amoxicillin-Clavulanate Potass, which accounts for 16 claims alone.

Medication Index

No matching medications currently found on file.

Amoxicillin-Clavulanate Potass

Generic Formulation: Amoxicillin/Potassium ClavSpecialty: Emergency Medicine
Provider Metrics Summary
Total Claims 16
30-Day Fills 16.0
Days Supply 120
MT State Average Benchmarks
Peer Average Claims21.0
Peer Average 30-Day Fills21.6
Peer Average Days Supply204
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $134.99 across this reporting matrix range.

Provider Avg Cost Per Claim

$8.44

State Avg Cost Per Claim

$12.26

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A fixed-ratio combination of amoxicillin trihydrate and potassium clavulanate.

Therapeutic Applications

Amoxicillin/clavulanic acid is a combination penicillin-type antibiotic used to treat a wide variety of bacterial infections. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

Azithromycin

Generic Formulation: AzithromycinSpecialty: Emergency Medicine
Provider Metrics Summary
Total Claims 11
30-Day Fills 11.0
Days Supply 53
MT State Average Benchmarks
Peer Average Claims26.0
Peer Average 30-Day Fills28.7
Peer Average Days Supply311
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 57.7% less volume than the regional standard for practitioners inside MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $48.89 across this reporting matrix range.

Provider Avg Cost Per Claim

$4.44

State Avg Cost Per Claim

$9.99

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A semi-synthetic macrolide antibiotic structurally related to ERYTHROMYCIN. It has been used in the treatment of Mycobacterium avium intracellulare infections, toxoplasmosis, and cryptosporidiosis.

Therapeutic Applications

This medication is used to treat certain eye infections. It is a macrolide antibiotic that works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness.

Prednisone

Generic Formulation: PrednisoneSpecialty: Emergency Medicine
Provider Metrics Summary
Total Claims 13
30-Day Fills 13.0
Days Supply 65
MT State Average Benchmarks
Peer Average Claims37.0
Peer Average 30-Day Fills47.3
Peer Average Days Supply936
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 64.9% less volume than the regional standard for practitioners inside MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $38.06 across this reporting matrix range.

Provider Avg Cost Per Claim

$2.93

State Avg Cost Per Claim

$6.75

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.

Therapeutic Applications

Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions.

Tramadol Hcl

Generic Formulation: Tramadol HclSpecialty: Emergency Medicine
Provider Metrics Summary
Total Claims 11
30-Day Fills 11.0
Days Supply 88
MT State Average Benchmarks
Peer Average Claims44.0
Peer Average 30-Day Fills45.8
Peer Average Days Supply927
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 75.0% less volume than the regional standard for practitioners inside MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $51.06 across this reporting matrix range.

Provider Avg Cost Per Claim

$4.64

State Avg Cost Per Claim

$6.91

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A narcotic analgesic proposed for severe pain. It may be habituating.

Therapeutic Applications

See also Warning section. This medication is used to help relieve moderate to moderately severe pain. Tramadol belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like SCOTT A RUNDLE MD provides transparency into local medical care patterns within Whitefish, MT.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Emergency Medicine** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.